IbogaBaseThe Iboga Evidence Base
Clinical boundary Schedule I in the U.S. Serious cardiac risk Not FDA-approved No dosing or referrals Schedule I · cardiac risk Not FDA-approved · no referrals

Claim check

The FDA allowed Noribogaine, so it is approved.

FDA allowed an early phase study to proceed. That is not approval and does not establish safety or effectiveness.

VERDICT False

“The FDA allowed Noribogaine, so it is approved.”

FDA allowed an early phase study to proceed. That is not approval and does not establish safety or effectiveness.

FDA · Policy